Blood test to help diagnose and predict liposarcoma
Treatments studied
Part of Cancer clinical trials.
This study looks for a new blood test marker that may help doctors diagnose liposarcoma and estimate how it may behave over time. You may be asked for a blood sample and consent, and the study may follow you to see how well the test works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- If you have liposarcoma: you had surgery for a localized or returning tumor, or you have a deep fat tumor over 5 cm
- You are willing to have a blood sample taken
- You can sign informed consent
- You should not be receiving (or planning) treatment before surgery for this cancer (no neoadjuvant therapy)
- You must be able to complete follow-up visits; severe mental health or social barriers may prevent participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how liposarcoma patients participate in research. You might help by reporting your experiences electronically.
This trial tests two targeted drugs – mirdametinib and palbociclib – taken as pills for people with a specific aggressive type of liposarcoma (dedifferentiated liposarcoma) that has spread or can't be removed. The goal is to see if this combination can shrink or slow the tumor.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study collects information and blood samples from adults with sarcoma who had surgery and possibly radiation. The goal is to build a large dataset that helps researchers understand sarcoma better and improve future care.
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
Hear when a new Liposarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.